DrugPatentWatch Database Preview
ALTOPREV Drug Profile
» See Plans and Pricing
Which patents cover Altoprev, and what generic alternatives are available?
Altoprev is a drug marketed by Covis and is included in one NDA.
The generic ingredient in ALTOPREV is lovastatin. There are thirty-three drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the lovastatin profile page.
US ANDA Litigation and Generic Entry Outlook for Altoprev
A generic version of ALTOPREV was approved as lovastatin by ACTAVIS ELIZABETH on December 17th, 2001.
Summary for ALTOPREV
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 105 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,584 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ALTOPREV |
| What excipients (inactive ingredients) are in ALTOPREV? | ALTOPREV excipients list |
| DailyMed Link: | ALTOPREV at DailyMed |
Recent Clinical Trials for ALTOPREV
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Amgen | Phase 4 |
| Brigham and Women's Hospital | Phase 4 |
Pharmacology for ALTOPREV
| Drug Class | HMG-CoA Reductase Inhibitor |
| Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
US Patents and Regulatory Information for ALTOPREV
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-001 | Jun 26, 2002 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-004 | Jun 26, 2002 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-002 | Jun 26, 2002 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-003 | Jun 26, 2002 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ALTOPREV
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-003 | Jun 26, 2002 | Start Trial | Start Trial |
| Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-001 | Jun 26, 2002 | Start Trial | Start Trial |
| Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-002 | Jun 26, 2002 | Start Trial | Start Trial |
| Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-004 | Jun 26, 2002 | Start Trial | Start Trial |
| Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-002 | Jun 26, 2002 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ALTOPREV
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Israel | 149524 | Start Trial |
| Canada | 2390301 | Start Trial |
| Hong Kong | 1050134 | Start Trial |
| World Intellectual Property Organization (WIPO) | 9948488 | Start Trial |
| Japan | 4646400 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
